Navigation Links
Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities
Date:12/1/2009

NEW YORK, Dec. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities

http://www.reportlinker.com/p0164526/Contract-Research-Outsourcing-CRO---A-Global-Update-of-Market-Trends--Opportunities.html

Contract Research Outsourcing (CRO), which came into being in the seventies, evolved into an essential component of pharmaceutical market scenario. CRO has emerged as a topic of great interest in the global pharmaceutical and biotechnology markets. Patent expiries, heightened competition in generic drug space, and dwindling drug discoveries necessitate research and development (R&D), innovation, and marketing of new pharma and biotech products to combat price fixing and cost escalations. Smaller product life spans, worldwide regulatory challenges, and the increasingly slim deadlines for clinical development magnify in-house R&D expenditure and affect productivity. The CRO concept emerged as a means to control in-house R&D costs, expand capacities, and improve core skills. Contract research organizations now offer a whole array of expert services ranging from pharmacology, pre-clinical safety evaluation, clinical trial management, study design, statistical analysis, regulatory services, and data collection to product support.

These and other market data and trends are presented in "Contract Research Outsourcing: A Global Update of Market Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

CONTRACT RESEARCH OUTSOURCING (CRO) BMR-6003

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. INDUSTRY OVERVIEW 4

Background 4

Growth and Transformation of CRO Industry 4

Advantages of CRO for Pharma and Biotech Companies 5

Advantages of CRO for Clinical Research Organizations 5

3. INDUSTRY POTENTIAL 5

Outlook 5

Competition Potential 6

Regional Potential 9

The United States 9

Western Europe 9

Central and Eastern Europe 9

Asia-Pacific 10

China 10

India 10

Latin America 10

Service Potential 10

Pre-Clinical Segment Gains Momentum 11

Clinical Research - Encouraging Factors at Various Phases 11

Phase I 11

Phase II 11

Phase III 11

Phase IV 12

Research & Development Potential 12

4. MARKET DYNAMICS 13

Challenges Faced by Contract Research Organizations 13

On-shore versus Offshore CRO Business 13

Cutthroat Competition Among CROs 13

Management of Production Capacities 14

Management of Clinical Investigation 14

Cost Containment 14

Safety Concerns on Clinical Trials 14

Pipeline Blocks 14

Strategies and Tactical Programs for CROs 14

Survival Strategies in Mature CRO Markets 15

Exit from the Industry 15

Expand Scale 15

Capture Niche Segments 15

Expand Geographically 15

Strategies to Tap Opportunities in Growing Markets 15

Mobilize Funds 15

Expand Other Services 16

Upgrade Technological and Knowledge Base 16

Form Sub-Contracts or Regional Alliances 16

Asia - Hub for Contract Research Outsourcing 16

Overview 16

Market Potential 16

Activity Perspective 17

Cost-Efficiency in Research and Development 17

World-Class Clinical Trials 17

Regional Perspective 17

China 17

Congenial Business Environment 17

Compliance with Global CRO Standards 18

Return of Skilled Human Resources 18

Availability of Large Genetic Population 18

Cost Advantages 18

India 18

Large Talent Pool of Human Resources 18

Increased Regulatory Compliance 18

Rich Genetic Diversity 19

Cost-Savings and World-Class Quality 19

Challenges in Outsourcing 19

China 19

Regulatory Hurdles 19

Limited Funding Resources 20

Demand War for Talented Personnel 20

Teething problems 20

Cultural and Language Difficulties 20

India 20

Restrictions on Clinical Trials 20

Lack of Standardization 20

Advantage India - hot spot for R&D investment 20

Subject-compliance in major therapeutic areas 20

Reliable Data Generation and Management 21

Improved Base of Medical Infrastructure 21

Strong Combination of CMOs and CROs 21

Reverse-engineering Capabilities 21

Market Trends 21

Biotech Leads in CRO 22

5. CORPORATE DEVELOPMENTS 22

Symyx Takes Over Integrity Biosolution 22

Worldwide Clinical Trials Acquires MediQuest 23

BioImagene Launches a New CRO, AgilityBio 23

Tigermed Receives Investments from Qiming 23

Covance Inks MoU with WuXi for a Chinese Joint Venture 23

Veeda Takes Over International Oncology Network 24

Kendle Acquires DecisionLine 24

Encorium to Take Over Prologue Research 24

PharmaLinkFHI Takes Over Matrix Contract Research Ltd. 24

Encorium Receives Business Contracts for North America and Europe 25

India's Jubilant Organosys to Takeover Draxis Health 25

Shasun to Establish Process Development Unit in US 25

Quintiles to Open Second Clinical Research Office in Wilmington 26

LabCorp to Acquire Tandem Labs 26

Shasun to Establish Process Development Unit in US 26

MDS Pharma Expands in Latin America 26

Iris Pharma and Clirophtha Merge to form New Iris Pharma 27

PPD to Acquire InnoPharm 27

KCR Acquires DUX Consuling 27

Cetero Research Acquires DGD Research 27

Jubilant Organosys Acquires Hollister-Stier Laboratories 27

Shasun Acquires Rhodia Pharma Plants 28

Ocimum Biosolutions Acquires Gene Logic's Genomics Business 28

Innovative Medical Device Sourcing Acquires Frontier

BioMedical LLC 28

UK-Based Premier Research Group PLC Acquires ARS, Inc. 28

AAIPharma, Inc. Acquires Instituto de Pesquisa Clinica de Sao

Paulo Ltda 28

Covance to Renovate New Drug Development Facility in Virginia 29

Covance Expands and Reshuffles Research Clinic 29

Perceptive Informatics Alliance To Enhance Clinical Supply

Chain Forecasting and Management 29

Genstar Capital Acquires PRA International 29

Covalent Acquires Remedium Oy and Changes Name to Encorium 30

Quintiles Enters Into a New Alliance with Washington County

Hospital 30

Kendle Expands in US and Europe 30

Criterium Opens Two New Offices in Russia and Israel 30

Premier Research Acquires Two Companies to Expand Product

Offerings 30

Averion Divests Staffing Services Segment 30

Chiltern Acquires CTMS 31

Quintiles Acquires Bio-Trials 31

Parexel Acquires Apex International Clinical Research 31

Charles River Forms Joint Venture with BioExplorer 31

PAREXEL Opens New Location In India 31

Avesthagen and Manipal Accunova Collaborate 32

Matrix and ethica Clinical Research form ethicamatrix 32

Covance Opens Nutritional Chemistry Laboratory in Singapore 32

MDS Pharma to Expand in European Market 32

Vita Nova Acquires Sedoc 33

Averion Acquires Hesperion 33

Averion and BIOCANCER Form Strategic Alliance 33

AstraZeneca Opens First CPU to Enhance Clinical Research in China 33

AstraZeneca Acquires Biologics Manufacturing Facility 33

AstraZeneca Inaugurates Global Process R&D Lab in Bangalore 33

6. MAJOR PLAYERS 34

Contract Research Organizations 34

Criterium, Inc. (US) 34

Covance, Inc. (US) 34

Encorium Group, Inc. (US) 34

ICON PLC (Ireland) 34

Kendle (US) 34

Life Sciences Research, Inc. (US) 35

MDS Pharma Services (US) 35

MPI Research (US) 35

Omnicare Clinical Research (US) 35

Parexel International Corporation (US) 35

PharmaNet Development Group, Inc. (US) 36

PRA International (US) 36

Pharmaceutical Product Development, Inc. (US) 36

Quintiles Transnational Corporation (US) 36

WIL Research Laboratories, LLC (US) 36

Preclinical Laboratories 37

Bio Analytical Research Corporation (US) 37

Calvert Laboratories, Inc. (US) 37

CentraLabS Clinical Research (US) 37

Charles River Laboratories, Inc. (US) 37

Huntingdon Life Sciences Research, Inc. (UK) 37

Laboratory Corporation of America® Holdings (US) 38

Lab Research, Inc. (Canada) 38

Pacific Biometrics, Inc. (US) 38

Perry Scientific, Inc. (US) 38

Quest Diagnostics, Inc. (US) 38

SNBL USA, Ltd. (US) 39

Site Management Organizations 39

DaVita Clinical Research (US) 39

nTouch Research Corporation (US) 39

PharmaTrials, Inc. (US) 39

Radiant Research, Inc. (US) 40

Research Solutions, LLC (US) 40

7. MARKET ANALYTICS 40

8. THE UNITED STATES 42

Market Overview 42

Competitive Scenario 43

9. EUROPE 44

Market Overview and Outlook 44

Competitive Scenario 44

Eastern Europe - Center for Clinical Trials 44

10. ASIA 46

Promising Market 46

Outsourcing Destinations: China and India 46

Promoting Role of the Government 47

Focus on Key Markets 47

India 47

A Thriving Clinical Trial Market 47

Reasons for Outsourcing to India 48

List of Pharmaceutical Companies Outsourcing Clinical

Research to India 49

SWOT Analysis 49

Competitive Scenario 50

Regulatory Environment 50

China 50

Factors Favoring Outsourcing Activity 50

SWOT Analysis 51

Policies Governing Clinical Trials 51

Clinical Research Market Size 51

11. REST OF WORLD 53

EXHIBITS

Table 1: Percentage Breakdown of Pipeline Drugs by Phase in

the World - 2007

Table 2: Percentage Breakup of Life Sciences Revenues of Major

Players by Service Type - 2007

Table 3: Number of CROs by Service Type in the World - 2007

Table 4: Market Shares of Pre-clinical CRO Providers in the

World - 2007

Table 5: Leading Biotechnology and Pharmaceutical Research

Companies Worldwide - Ranked by Year 2006 Revenues in US$

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition of the ... 2022" report to their offering. ... The global wound care market was worth $24,482.9 million in ... during 2016-2022 Among the various wound care products type, the ... market in 2015. Among the various applications, surgical wound segment held the ...
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets has announced ... report to their offering. ... This report analyzes the worldwide markets for Dental Implants in US$ ... Canada , Japan , Europe ... and Rest of World. Annual estimates and forecasts are ...
(Date:3/24/2017)... 2017 ShangPharma, a leading life ... drug development and discovery services, technology, and ... announced today the intent for a strategic ... consolidating the Contract Research Organizations (CRO) and ... These entities include ChemPartner Shanghai, ChemPartner Fengxian, ...
Breaking Medicine Technology:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... The homeowner ... the number of homeowners utilizing DIY and unlicensed contractors for renovations is also on ... or replacement project in 2015, and of those, 42% failed to use a licensed ...
(Date:3/24/2017)... ... March 24, 2017 , ... Clean ... dredged material, and hazardous and non-hazardous materials announced today the acquisition of privately ... acquisition will add four additional processing facilities and a vast array of additional ...
(Date:3/24/2017)... ... , ... The Radiology Business Management Association (RBMA) has named the ... their 12th year, are among the most prestigious in radiology marketing because a panel ... retooled to recognize achievements in both large budget (over $5,000) and small budget (under ...
(Date:3/24/2017)... ... March 24, 2017 , ... Shamanic healer and teacher ... Healing and Spiritual Awakening, proudly presents her Sacred Peru retreat with world ... and spiritual journey during the Summer Solstice will also be her final international ...
(Date:3/24/2017)... ... 24, 2017 , ... The law firm of Enea, Scanlan & Sirignano, ... Westchester resident Lauren C. Enea has joined the firm as an associate attorney. Ms. ... practice in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. ...
Breaking Medicine News(10 mins):